Russell Investments Group Ltd. Boosts Holdings in Bruker Corporation $BRKR

Key Points

• Russell Investments Group Ltd. increased its stake in Bruker Corporation by 154.7% in the first quarter, acquiring an additional 11,878 shares, bringing its total holdings to 19,558 shares valued at approximately $816,000.
• Bruker recently declared a quarterly dividend of $0.05 per share, which will be paid on October 3rd, indicating a dividend yield of 0.6% with a payout ratio of 38.46%.
• The company's stock has seen price target revisions from several analysts, with Bank of America lowering its target from $61.00 to $50.00, while five analysts rate the stock as "Buy" and six as "Hold."

Russell Investments Group Ltd. lifted its stake in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 154.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,558 shares of the medical research company's stock after purchasing an additional 11,878 shares during the period. Russell Investments Group Ltd.'s holdings in Bruker were worth $816,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in BRKR. Pinnacle Bancorp Inc. purchased a new position in Bruker during the first quarter worth approximately $29,000. Allworth Financial LP increased its stake in shares of Bruker by 92.4% in the 1st quarter. Allworth Financial LP now owns 758 shares of the medical research company's stock worth $30,000 after acquiring an additional 364 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in shares of Bruker in the 1st quarter worth $42,000. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Bruker by 274.9% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,091 shares of the medical research company's stock worth $46,000 after acquiring an additional 800 shares during the period. Finally, Fifth Third Bancorp boosted its position in shares of Bruker by 54.2% during the 1st quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company's stock valued at $46,000 after acquiring an additional 390 shares during the last quarter. Institutional investors and hedge funds own 79.52% of the company's stock.

Insider Activity at Bruker

In other news, CEO Frank H. Laukien acquired 2,608 shares of the company's stock in a transaction dated Friday, June 6th. The stock was acquired at an average cost of $38.36 per share, with a total value of $100,042.88. Following the completion of the purchase, the chief executive officer owned 38,462,171 shares of the company's stock, valued at $1,475,408,879.56. This represents a 0.01% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link. 27.30% of the stock is currently owned by corporate insiders.

Bruker Trading Up 0.0%

Shares of BRKR traded up $0.00 during trading on Thursday, reaching $29.35. 3,042,343 shares of the company traded hands, compared to its average volume of 2,533,774. The stock has a 50-day simple moving average of $37.59 and a 200-day simple moving average of $39.96. The stock has a market cap of $4.45 billion, a PE ratio of 56.16, a price-to-earnings-growth ratio of 2.79 and a beta of 1.21. Bruker Corporation has a twelve month low of $28.53 and a twelve month high of $72.94. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31.

Bruker (NASDAQ:BRKR - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.33 by ($0.01). The company had revenue of $797.40 million during the quarter, compared to analyst estimates of $811.17 million. Bruker had a return on equity of 17.89% and a net margin of 2.31%.The business's revenue was down .4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.52 earnings per share. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. On average, analysts anticipate that Bruker Corporation will post 2.69 earnings per share for the current year.

Bruker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd will be given a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 23rd. Bruker's dividend payout ratio (DPR) is currently 38.46%.

Analyst Ratings Changes

Several research firms recently issued reports on BRKR. Barclays cut their price objective on shares of Bruker from $46.00 to $43.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Jefferies Financial Group set a $60.00 price target on shares of Bruker and gave the company a "buy" rating in a research note on Monday, August 4th. UBS Group cut their price target on shares of Bruker from $57.00 to $45.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. The Goldman Sachs Group reduced their price target on shares of Bruker from $50.00 to $45.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Finally, Stifel Nicolaus set a $40.00 price objective on Bruker and gave the stock a "hold" rating in a research report on Tuesday, August 5th. Five research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $51.30.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.